About
Neuromodulation
Areas of Focus
Categories
Uncategorized Medical DeviceNJ, NY, PA
Clinical Trials (12)
View allTotal Trials
12
As Lead Sponsor
9
As Collaborator
3
Total Enrollment
410
By Phase
NA: 7PHASE1: 2PHASE2: 2
By Status
COMPLETED: 9RECRUITING: 3
Clinical Trials Pipeline12 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT07042217Lead Sponsor
Transcranial Direct Current Stimulation for Depression
NARecruiting
25 participants
Started: Jul 1, 2025 · Completed: Sep 1, 2026
NCT06783283Collaborator
TACS to Engage Theta-Gamma Coupling and Enhance Working Memory in Patients With MCI (tACS-MCI)
NARecruiting
20 participants
Started: Jan 2, 2025 · Completed: Dec 31, 2026
NCT05377411Collaborator
SMART Stimulation: Precision Neuromodulation of Cognition in Older Adults
NACompleted
33 participants
Started: Jan 17, 2023 · Completed: Jun 3, 2024
NCT05090267Collaborator
The Path Study: Cognitive and Inflammation Targeted Gut-brain Interventions in Alcohol; Probiotics, Alcohol, Transcutaneous Vagus Nerve Stimulation, and HIV Study
NARecruiting
80 participants
Started: Jun 1, 2022 · Completed: Jun 30, 2026
NCT04956081Lead Sponsor
Virtual Neuro-Navigation System for Personalized Community Based TMS
NACompleted
22 participants
Started: Jul 1, 2021 · Completed: Sep 1, 2025
Locations (1)
Headquarters
Woodbridge, NJ, United States
Map
Loading map...